Active Ingredient History
Dronabinol also known as (−)-trans-delta9-tetrahydrocannabinol is an active ingredient of cannabis. The drug was approved by FDA for the treatment of anorexia in patients with AIDS and chemotherapy-induced nausea and vomiting. Dronabinol exerts its action by activating CB1 and CB2 recepors which makes it a CNS active medicine. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abortion, Induced (Phase 4)
Acute Pain (Phase 2)
Adolescent Behavior (Early Phase 1)
Alcohol Drinking (Phase 2)
Alcohol-Induced Disorders (Phase 1)
Alcoholism (Phase 4)
Alzheimer Disease (Phase 2)
Analgesics, Opioid (Phase 4)
Anemia, Sickle Cell (Phase 2)
Anorexia (Phase 2)
Anorexia Nervosa (Phase 3)
Arthropathy, Neurogenic (Early Phase 1)
Arthroplasty, Replacement, Knee (Phase 4)
Atherosclerosis (Phase 1)
Behavior (Phase 2)
Behavioral Symptoms (Phase 2)
Biological Availability (Phase 1)
Bipolar Disorder (Early Phase 1)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Early Phase 1)
Cachexia (Phase 1)
Cannabis (Phase 4)
Cardiovascular Diseases (Phase 1)
Chest Pain (Phase 4)
Child Nutrition Disorders (Phase 2/Phase 3)
Chronic Pain (Phase 2/Phase 3)
Cognition Disorders (Early Phase 1)
Complex Regional Pain Syndromes (Phase 2)
Crohn Disease (Phase 1/Phase 2)
Dementia (Phase 2)
Dementia, Vascular (Phase 2)
Dermatology (Phase 2/Phase 3)
Diagnosis, Dual (Psychiatry) (Phase 1)
Dronabinol (Phase 1)
Drugs, Generic (Phase 1)
Dysautonomia, Familial (Phase 2)
Endocannabinoids (Phase 1)
Enteral Nutrition (Phase 4)
Esophageal Diseases (Phase 4)
Female (Early Phase 1)
Head and Neck Neoplasms (Phase 4)
Healthy Volunteers (Phase 4)
HIV (Phase 1)
HIV Infections (Phase 2)
HIV Wasting Syndrome (Phase 1)
Huntington Disease (Phase 2)
Irritable Bowel Syndrome (Phase 2)
Knee (Phase 3)
Knee Injuries (Phase 3)
Low Back Pain (Phase 2)
Lung Neoplasms (Phase 4)
Lymphoma (Phase 2/Phase 3)
Magnetic Resonance Imaging (Phase 1)
Marijuana Abuse (Phase 2/Phase 3)
Marijuana Smoking (Phase 1/Phase 2)
Marijuana Use (Phase 4)
Memory (Phase 1)
Meniscus (Phase 3)
Mental Disorders (Phase 1)
Mental Health (Phase 1)
Migraine with Aura (Phase 2)
Migraine without Aura (Phase 2)
Multiple Sclerosis (Phase 3)
Muscle Hypotonia (Phase 2/Phase 3)
Nausea (Phase 2)
Neoplasm Metastasis (Early Phase 1)
Neoplasms (Phase 4)
Neuralgia (Phase 2)
Neurosciences (Early Phase 1)
Obsessive-Compulsive Disorder (Phase 2)
Olfactory Nerve Diseases (Phase 2)
Opioid-Related Disorders (Phase 2/Phase 3)
Osteoarthritis, Knee (Phase 3)
Pain (Phase 4)
Pain, Postoperative (Phase 4)
Palliative Care (Phase 3)
Pancreatic Neoplasms (Phase 4)
Polymorphism, Genetic (Phase 1)
Pregnancy Complications (Phase 4)
Problem Behavior (Early Phase 1)
Psychomotor Agitation (Phase 2)
Psychotic Disorders (Phase 1)
Quality of Life (Phase 4)
Retinal Diseases (Phase 2)
Reward (Phase 1)
Schizophrenia (Phase 1/Phase 2)
Sleep (Early Phase 1)
Sleep Apnea, Obstructive (Phase 2/Phase 3)
Stress Disorders, Post-Traumatic (Phase 4)
Substance Abuse, Oral (Phase 1)
Substance-Related Disorders (Phase 1)
Taste Disorders (Phase 2)
Torticollis (Phase 2)
Tourette Syndrome (Phase 2)
Traumatology (Phase 4)
Trichotillomania (Phase 2/Phase 3)
Vomiting (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
